Corindus Vascular Robotics Stock Price, Forecast & Analysis (NYSEAMERICAN:CVRS)

Corindus Vascular Robotics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CVRS."

Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) announced its quarterly earnings data on Tuesday, August, 7th. The medical equipment provider reported ($0.06) EPS for the quarter, missing the Zacks' consensus estimate of ($0.05) by $0.01. The medical equipment provider had revenue of $1.67 million for the quarter, compared to analyst estimates of $3 million. View Corindus Vascular Robotics' Earnings History.

1 equities research analysts have issued twelve-month price objectives for Corindus Vascular Robotics' stock. Their forecasts range from $4.28 to $4.28. On average, they anticipate Corindus Vascular Robotics' stock price to reach $4.28 in the next twelve months. This suggests a possible upside of 0.2% from the stock's current price. View Analyst Price Targets for Corindus Vascular Robotics.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Corindus Vascular Robotics in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Corindus Vascular Robotics.

Media headlines about CVRS stock have been trending negative on Friday, according to InfoTrie Sentiment Analysis. The research group ranks the sentiment of news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Corindus Vascular Robotics earned a daily sentiment score of -2.5 on InfoTrie's scale. They also assigned news stories about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for Corindus Vascular Robotics.

Corindus Vascular Robotics saw a drop in short interest during the month of October. As of October 15th, there was short interest totalling 8,700,000 shares, a drop of 7.6% from the September 15th total of 9,420,000 shares. Based on an average daily volume of 3,240,000 shares, the short-interest ratio is currently 2.7 days. Currently, 6.8% of the shares of the company are sold short. View Corindus Vascular Robotics' Current Options Chain.

Some companies that are related to Corindus Vascular Robotics include Consort Medical (CSRT), Ekf Diagnostics (EKF), Immunodiagnostic Systems (IDH), Theralase Technologies (TLT), Intelligent Ultrasound Group (MED), LiDCO Group (LID), Deltex Medical Group (DEMG), Zecotek Photonics (ZMS), InspireMD (NSPR), Lucid (LCDX), MCP Income Opp Trust Ordinary Units FP (MOT) and Verisante Technology (VRS).

Based on aggregate information from My MarketBeat watchlists, some companies that other Corindus Vascular Robotics investors own include Amarin (AMRN), TransEnterix (TRXC), Micron Technology (MU), Advanced Micro Devices (AMD), Alibaba Group (BABA), Helios and Matheson Analytics (HMNY), TherapeuticsMD (TXMD), Viking Therapeutics (VKTX), Exelixis (EXEL) and NVIDIA (NVDA).

Corindus Vascular Robotics' stock is owned by many different of institutional and retail investors. Top institutional investors include ARP Americas LP (0.64%), GABELLI & Co INVESTMENT ADVISERS INC. (0.45%), Gabelli Funds LLC (0.37%), Havens Advisors LLC (0.16%), Harvest Management LLC (0.10%) and Tokio Marine Asset Management Co. Ltd. (0.07%). Company insiders that own Corindus Vascular Robotics stock include Hudson Executive Capital Lp and Louis A Cannon. View Institutional Ownership Trends for Corindus Vascular Robotics.

CVRS stock was bought by a variety of institutional investors in the last quarter, including ARP Americas LP, GABELLI & Co INVESTMENT ADVISERS INC., Gabelli Funds LLC, Havens Advisors LLC, Harvest Management LLC, Tokio Marine Asset Management Co. Ltd., Syquant Capital Sas and Gamco Investors INC. ET AL. Company insiders that have bought Corindus Vascular Robotics stock in the last two years include Hudson Executive Capital Lp and Louis A Cannon. View Insider Buying and Selling for Corindus Vascular Robotics.

Shares of CVRS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CVRS stock can currently be purchased for approximately $4.27.

Corindus Vascular Robotics has a market capitalization of $891.08 million. Corindus Vascular Robotics employs 90 workers across the globe.View Additional Information About Corindus Vascular Robotics.

The official website for Corindus Vascular Robotics is http://www.corindus.com/.

Corindus Vascular Robotics' mailing address is 309 Waverley Oaks Rd Ste 105, WALTHAM, MA 02452-8451, United States. The medical equipment provider can be reached via phone at +1-508-6533335.